Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Lymphoma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Phase%3A+Phase+2%22&type=Subject&filter%5B%5D=topic_facet%3A%22Lymphoma%22
/vufind/Search/Results?lookfor=%22Phase%3A+Phase+2%22&type=Subject&filter%5B%5D=topic_facet%3A%22Lymphoma%22
Search /vufind/Search2/Results?lookfor=%22Phase%3A+Phase+2%22&type=Subject&filter%5B%5D=topic_facet%3A%22Lymphoma%22
PubPharm (1.988)
1
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma : Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma : A Randomized Phase 2 Trial of Brentuximab Vedotin (SGN35, NSC# 749710), or Crizotinib (NSC#749005, Commercially Labeled) in Combination With Chemotherapy for Newly Diagnosed Patients With Anaplastic Large Cell Lymphoma (ALCL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) : Molecular Analysis for Therapy Choice (MATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Ensartinib in Patients With Tumors Harboring ALK or ROS1 Genomic Alterations
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma : An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/ Refractory Follicular Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma : Phase II Study of Second-line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma : A Phase 2 Study of Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients : A Pivotal Phase II Randomised, Multi-centre, Open-label Study to Evaluate the Efficacy and Safety of MB-CART2019.1 Compared to SoC Therapy in Participants With r/r DLBCL, Who Are Not Eligible for HDC and ASCT
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL) : A Phase 2 Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of XmAb13676 (Plamotamab) Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[199]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Lymphoma
Medienart
1.988
Aufsätze
1.988
E-Artikel
1.988
E-Ressourcen
Zeitschriftentitel
1.988
ClinicalTrials.gov
Thema
1.988
610
Lymphoma
1.988
Study Type: Interventional
1.947
Phase: Phase 2
720
Recruitment Status: Completed
471
Lymphoma, B-Cell
454
Recruitment Status: Recruiting
448
Lymphoma, Non-Hodgkin
400
Lymphoma, Large B-Cell, Diffuse
304
Recruitment Status: Active, not recruiting
296
Leukemia
257
Lymphoma, T-Cell
244
Lymphoma, Mantle-Cell
236
Hodgkin Disease
231
Recruitment Status: Terminated
208
Lymphoma, Follicular
197
Leukemia, Lymphocytic, Chronic, B-Cell
191
Leukemia, Lymphoid
139
Multiple Myeloma
138
Lymphoma, T-Cell, Peripheral
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.231
2020-
717
2010-2019
40
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.988
Englisch
Haven't found what you're looking for?
Wird geladen...